To date, 23 states and the District of Columbia have enacted legislation to make cannabis available to people with medical conditions that can be alleviated using the drug. Many people understand the laws in terms of offering compassionate pain relief and appetite stimulation for people suffering devastating illnesses like cancer and HIV/AIDS.Read More
Up at 5AM: The 5AM Solutions Blog
From a device that shows promise in lengthening the lives of patients with glioblastomas to using magnets to decrease concussions on the football field, this week is full of good (or at least very interesting) science and health news.Read More
The Sixth Annual Next Generation Dx Summit (NGDx) was the first conference I have attended in quite a few years. I was drawn to it by its emphasis on new research areas in clinical assay development and how the biomedical industry can bring these potentially life-saving diagnostics to market to fight diseases and benefit personalized medicine (PM). I decided to focus on two tracks for the conference. Companion Diagnostics: Strategy & Partnerships appealed to my personalized medicine interests and Clinical Application of Cell-Free DNA allowed me to see new research on a specific application of a potentially game-changing diagnostic approach.Read More
Last week, we did a post on curing cancer at the gene-level. But what about using genes to diagnose cancer? A feature story in the MIT Technology Review looks at research happening at Johns Hopkins University on that very possibility.
Experts around the globe agree that most skin cancers are preventable. They disagree, however, on what skin cancer prevention looks like.
DIA kicked off its 50th Annual Meeting in San Diego, yesterday, where the theme is "Celebrate the Past - Invent the Future." The future (or part of it, anyway) seems to have arrived at DIA 2014 where, from keynote to closing, patient advocates have a prominent seat at the head of the table; a table previously reserved for health care professionals. It makes us hopeful: is the personalized, patient-centered future here?
Who doesn’t like a scientific breakthrough? The media buzzes with news from the frontiers of science that directly affects us: biological and medical research. The stories that really get our attention are those in which new technologies solve medical mysteries or save lives.
The Surgeon General's "My Family Health Portrait" -- a tool developed by 5AM and a team of collaborators -- was recently referenced in the the book "The End of Illness" by David B. Agus. Dr. Agus is professor of medicine and Engineering at USC Keck School of medicine. He is the founder of Oncology.com and served as attending physician and as head of the Laboratory of Tumor Biology at Memorial Sloan-Kettering Cancer Center. In "The End of Illness," Agus suggests that as a society we should change our view of health and wellness, and offers that we have been thinking about our bodies in an incorrect manner. One interesting concept the author addresses is how certain diseases and conditions can be addressed through early detection and changes to habits and lifestyle. Essentially, we shouldn't focus on the late stage solution for a particular condition if it is possible to prevent the condition to begin with. Agus suggests natural behavioral "prescriptions" -- such as wearing a comfortable pair of shoes and eating lunch at the same time every day -- can improve one's health. He also explores the positive and negative consequences of different drugs and the statistics behind the change in death rates of particular conditions over the last few decades as certain drugs have been introduced to the market.
When you hear the word “cancer,” the type that often rests front of mind in the modern era is breast cancer. You can’t escape references to it in popular culture because it is everywhere. Entire merchandising lines of pink-themed items, special events, races, walks, fundraisers and friendraisers abound throughout the year. There is support, there is acceptance, and there is undoubtedly awareness—all leading to ample financial backing for research and treament.